ESSERRE Trademark

Trademark Overview


On Friday, December 2, 2022, a trademark application was filed for ESSERRE with the United States Patent and Trademark Office. The USPTO has given the ESSERRE trademark a serial number of 79365506. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by ESSERRE PHARMA S.R.L.. The ESSERRE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical and natural medicines for the treatment of cardiometabolic and cardiovascular risk factors, vascular disease, gastrointestinal disorders, inflammation and edema of tissues, flu, cough and cold, fatigue, malnutrition, sarcopenia, immune system deficiencies, allergy, hypovitaminosis, cognitive impairment, mental disorders, sleep disorders, musculoskeletal aches, osteoarticular disorders, skin disorders, nails and hair disorders, electrolyte imbalances, anemia, mineral deficiency, headache, urogenital disorders, gynecological disorders, infertility, dental disorders, hepatobiliary disorders, pancreatic disorders, liver disease, obesity, diabetes, eye disease, respiratory system disease, ulcers, trauma; Food supplements and dietary preparations being dietary supplements for the treatment of cardiometabolic and cardiovascular risk factors, vascular disease, gastrointestinal disorders, inflammation and edema of tissues, flu, cough and cold, fatigue, malnutrition, sarcopenia, i...

Chemical and organic compositions in the nature of fruit extracts and nutraceuticals for the manufacture of food and drink; Chemical substances, chemical materials and preparations, and natural elements being fruit extracts and nutraceuticals for use in the manufacture of food supplements and cosmetics; Chemical compounds and materials for use in science, namely, reagents for scientific use; Chemical compounds and materials being additives for use in the manufacture of cosmetics; Chemicals for use in the manufacture of pharmaceuticals; Plant extracts for use in the manufacture of pharmaceutical products; Vitamins for use in the manufacture of pharmaceutical products; chemicals for use in the manufacture of food supplements; Plant extracts for use in the manufacture of food supplements; plant extracts for use in the food industry, namely, plant extracts in the manufacture of foods; plant extracts for use in the manufacture of cosmetics; Botanical extracts, other than essential oils, for...
esserre

General Information


Serial Number79365506
Word MarkESSERRE
Filing DateFriday, December 2, 2022
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7435507
Registration DateTuesday, July 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesPharmaceutical and natural medicines for the treatment of cardiometabolic and cardiovascular risk factors, vascular disease, gastrointestinal disorders, inflammation and edema of tissues, flu, cough and cold, fatigue, malnutrition, sarcopenia, immune system deficiencies, allergy, hypovitaminosis, cognitive impairment, mental disorders, sleep disorders, musculoskeletal aches, osteoarticular disorders, skin disorders, nails and hair disorders, electrolyte imbalances, anemia, mineral deficiency, headache, urogenital disorders, gynecological disorders, infertility, dental disorders, hepatobiliary disorders, pancreatic disorders, liver disease, obesity, diabetes, eye disease, respiratory system disease, ulcers, trauma; Food supplements and dietary preparations being dietary supplements for the treatment of cardiometabolic and cardiovascular risk factors, vascular disease, gastrointestinal disorders, inflammation and edema of tissues, flu, cough and cold, fatigue, malnutrition, sarcopenia, immune system deficiencies, allergy, hypovitaminosis, cognitive impairment, mental disorders, sleep disorders, musculoskeletal aches, osteoarticular disorders, skin disorders, nails and hair disorders, electrolyte imbalances, anemia, mineral deficiency, headache, urogenital disorders, gynecological disorders, infertility, dental disorders, hepatobiliary disorders, pancreatic disorders, liver disease, obesity, diabetes, eye disease, respiratory system disease, ulcers, trauma; Pharmaceutical products, namely, skin lotions and dermatological preparations
Translation of Words in MarkThe wording "ESSERRE" has no meaning in a foreign language.
Goods and ServicesChemical and organic compositions in the nature of fruit extracts and nutraceuticals for the manufacture of food and drink; Chemical substances, chemical materials and preparations, and natural elements being fruit extracts and nutraceuticals for use in the manufacture of food supplements and cosmetics; Chemical compounds and materials for use in science, namely, reagents for scientific use; Chemical compounds and materials being additives for use in the manufacture of cosmetics; Chemicals for use in the manufacture of pharmaceuticals; Plant extracts for use in the manufacture of pharmaceutical products; Vitamins for use in the manufacture of pharmaceutical products; chemicals for use in the manufacture of food supplements; Plant extracts for use in the manufacture of food supplements; plant extracts for use in the food industry, namely, plant extracts in the manufacture of foods; plant extracts for use in the manufacture of cosmetics; Botanical extracts, other than essential oils, for use in the manufacture of cosmetics

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, March 20, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameESSERRE PHARMA S.R.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIT

Party NameESSERRE PHARMA S.R.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIT

Party NameESSERRE PHARMA S.R.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIT

Trademark Events


Event DateEvent Description
Thursday, March 16, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, March 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 24, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, September 12, 2023ASSIGNED TO EXAMINER
Wednesday, September 20, 2023NON-FINAL ACTION WRITTEN
Thursday, September 21, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 3, 2023REFUSAL PROCESSED BY MPU
Tuesday, October 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 25, 2023REFUSAL PROCESSED BY IB
Tuesday, January 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 9, 2024FINAL REFUSAL WRITTEN
Saturday, March 9, 2024FINAL REFUSAL E-MAILED
Saturday, March 9, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, March 15, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, March 15, 2024EXAMINERS AMENDMENT E-MAILED
Friday, March 15, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 15, 2024EXAMINER'S AMENDMENT ENTERED
Friday, March 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 3, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Thursday, April 25, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 2, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 23, 2024NOTIFICATION PROCESSED BY IB